Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamie Michael

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
The Prostate|June 20, 2025
Genomic Signatures Correlating With Adverse Pathologic Features in Men Eligible for Active SurveillanceJamie Michael, Eric V Li, Mitch Huang, et al.
NPJ Precision Oncology|March 20, 2026
Prediction of molecular subtypes from histology: AI-driven analysis of prostate cancer morphological patterns and therapeutic implicationsRamin Nateghi, Aoran Sun, Hao Dang, et al.
European Urology Oncology|May 11, 2025
Prevalence of Potential Candidates for Targeted Therapies According to Treatment-related Transcriptomic Signatures Among 140 548 Patients with Nonmetastatic Prostate CancerNicole Handa, Eric V Li, Jamie Michael, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
The Prostate|June 20, 2025
Genomic Signatures Correlating With Adverse Pathologic Features in Men Eligible for Active SurveillanceJamie Michael, Eric V Li, Mitch Huang, et al.
NPJ Precision Oncology|March 20, 2026
Prediction of molecular subtypes from histology: AI-driven analysis of prostate cancer morphological patterns and therapeutic implicationsRamin Nateghi, Aoran Sun, Hao Dang, et al.
European Urology Oncology|May 11, 2025
Prevalence of Potential Candidates for Targeted Therapies According to Treatment-related Transcriptomic Signatures Among 140 548 Patients with Nonmetastatic Prostate CancerNicole Handa, Eric V Li, Jamie Michael, et al.
Pageof 3